PL2922571T3 - Postać farmaceutyczna zawierająca metaloporfiryny zawierające karboran - Google Patents

Postać farmaceutyczna zawierająca metaloporfiryny zawierające karboran

Info

Publication number: PL2922571T3
Authority: PL; Poland
Prior art keywords: metalloporphirines; carborate; pharmaceutical form; form containing; pharmaceutical
Prior art date: 2012-11-23

Application number

PL13801495T

Other languages

English (en)

Inventor

Chris Beattie

James Rennie

Anne Wadsworth

Original Assignee

Morex Development Partners Llp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-11-23

Filing date

2013-11-22

Publication date

2018-03-30

2013-11-22 Application filed by Morex Development Partners Llp filed Critical Morex Development Partners Llp

2018-03-30 Publication of PL2922571T3 publication Critical patent/PL2922571T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
- A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0485—Porphyrins, texaphyrins wherein the nitrogen atoms forming the central ring system complex the radioactive metal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physics & Mathematics (AREA)
Optics & Photonics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

PL13801495T 2012-11-23 2013-11-22 Postać farmaceutyczna zawierająca metaloporfiryny zawierające karboran PL2922571T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB1221125.6A GB201221125D0 (en)	2012-11-23	2012-11-23	Pharmaceutial formulations
EP13801495.6A EP2922571B1 (en)	2012-11-23	2013-11-22	Pharmaceutical formulations comprising carborane-containing metallo-porphyrins
PCT/EP2013/074490 WO2014079977A1 (en)	2012-11-23	2013-11-22	Pharmaceutical formulations

Publications (1)

Publication Number	Publication Date
PL2922571T3 true PL2922571T3 (pl)	2018-03-30

Family

ID=47560584

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL13801495T PL2922571T3 (pl)	2012-11-23	2013-11-22	Postać farmaceutyczna zawierająca metaloporfiryny zawierające karboran

Country Status (21)

Country	Link
US (1)	US9358290B2 (pl)
EP (1)	EP2922571B1 (pl)
JP (1)	JP6279599B2 (pl)
KR (1)	KR20150086283A (pl)
CN (1)	CN104853777B (pl)
CA (1)	CA2890271A1 (pl)
CY (1)	CY1119713T1 (pl)
DK (1)	DK2922571T3 (pl)
ES (1)	ES2646010T3 (pl)
GB (1)	GB201221125D0 (pl)
HK (1)	HK1209339A1 (pl)
HR (1)	HRP20171652T1 (pl)
HU (1)	HUE035198T2 (pl)
LT (1)	LT2922571T (pl)
NO (1)	NO2922571T3 (pl)
PL (1)	PL2922571T3 (pl)
PT (1)	PT2922571T (pl)
RS (1)	RS56499B1 (pl)
SI (1)	SI2922571T1 (pl)
SM (1)	SMT201700512T1 (pl)
WO (1)	WO2014079977A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201212409D0 (en) *	2012-07-12	2012-08-22	Morex Dev Partners Llp	Cancer treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4925736A (en)	1988-07-06	1990-05-15	Long Island Jewish Medical Center	Topical hematoporphyrin
US7090691B2 (en)	2001-11-09	2006-08-15	Qlt Inc.	Photodynamic therapy for the treatment of hair loss
US6995260B2 (en) *	2004-05-20	2006-02-07	Brookhaven Science Associates, Llc	Carboranylporphyrins and uses thereof
US8287839B2 (en) *	2006-12-04	2012-10-16	Brookhaven Science Associates, Llc	Carboranylporphyrins and uses thereof
US8444953B2 (en) *	2007-03-22	2013-05-21	Brookhaven Science Associates, Llc	Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof
CN101815673B (zh)	2007-09-03	2013-07-10	Dic株式会社	纳米结构复合体覆盖型结构物的制造方法、纳米结构复合体覆盖型结构物以及使用该结构物的反应器
GB0819594D0 (en)	2008-10-24	2008-12-03	Univ Coimbrra	Process
GB201212409D0 (en)	2012-07-12	2012-08-22	Morex Dev Partners Llp	Cancer treatment

2012
- 2012-11-23 GB GBGB1221125.6A patent/GB201221125D0/en not_active Ceased
2013
- 2013-11-22 DK DK13801495.6T patent/DK2922571T3/da active
- 2013-11-22 JP JP2015543441A patent/JP6279599B2/ja not_active Expired - Fee Related
- 2013-11-22 PL PL13801495T patent/PL2922571T3/pl unknown
- 2013-11-22 ES ES13801495.6T patent/ES2646010T3/es active Active
- 2013-11-22 HU HUE13801495A patent/HUE035198T2/hu unknown
- 2013-11-22 PT PT138014956T patent/PT2922571T/pt unknown
- 2013-11-22 CN CN201380060998.8A patent/CN104853777B/zh not_active Expired - Fee Related
- 2013-11-22 EP EP13801495.6A patent/EP2922571B1/en active Active
- 2013-11-22 US US14/646,527 patent/US9358290B2/en not_active Expired - Fee Related
- 2013-11-22 WO PCT/EP2013/074490 patent/WO2014079977A1/en active Application Filing
- 2013-11-22 RS RS20171110A patent/RS56499B1/sr unknown
- 2013-11-22 KR KR1020157013960A patent/KR20150086283A/ko not_active Ceased
- 2013-11-22 SI SI201330816T patent/SI2922571T1/sl unknown
- 2013-11-22 SM SM20170512T patent/SMT201700512T1/it unknown
- 2013-11-22 NO NO13801495A patent/NO2922571T3/no unknown
- 2013-11-22 CA CA2890271A patent/CA2890271A1/en not_active Abandoned
- 2013-11-22 LT LTEP13801495.6T patent/LT2922571T/lt unknown
2015
- 2015-10-15 HK HK15110095.6A patent/HK1209339A1/xx not_active IP Right Cessation
2017
- 2017-10-30 HR HRP20171652TT patent/HRP20171652T1/hr unknown
- 2017-10-31 CY CY20171101132T patent/CY1119713T1/el unknown

Also Published As

Publication number	Publication date
EP2922571B1 (en)	2017-09-06
US9358290B2 (en)	2016-06-07
JP6279599B2 (ja)	2018-02-14
DK2922571T3 (da)	2017-11-13
CN104853777B (zh)	2019-03-08
KR20150086283A (ko)	2015-07-27
CA2890271A1 (en)	2014-05-30
CY1119713T1 (el)	2018-06-27
JP2016500090A (ja)	2016-01-07
LT2922571T (lt)	2017-11-10
SI2922571T1 (sl)	2017-12-29
ES2646010T3 (es)	2017-12-11
HK1209339A1 (en)	2016-04-01
WO2014079977A1 (en)	2014-05-30
GB201221125D0 (en)	2013-01-09
HUE035198T2 (hu)	2018-05-02
HRP20171652T1 (hr)	2017-12-15
SMT201700512T1 (it)	2018-01-11
NO2922571T3 (pl)	2018-02-03
CN104853777A (zh)	2015-08-19
US20150297717A1 (en)	2015-10-22
EP2922571A1 (en)	2015-09-30
PT2922571T (pt)	2017-11-07
RS56499B1 (sr)	2018-01-31

Publication	Publication Date	Title
DK3181128T3 (da)	2023-06-06	Farmaceutisk nilotinib-sammensætning
DK3858405T3 (da)	2023-07-03	Sprøjte
DK3381444T3 (da)	2021-08-09	Sprøjte
CL2013001765S1 (es)	2014-01-24	Contenedor
DK2897594T3 (da)	2020-06-29	Farmaceutisk sammensætning
EP2883547A4 (en)	2016-02-10	MEDICINE
EP2913076A4 (en)	2016-08-17	SYRINGE
DK2854765T3 (da)	2019-07-01	Farmaceutisk pemetrexed-opløsning
BR112015002683A2 (pt)	2017-07-04	recipiente
CL2013001709S1 (es)	2014-07-25	Envase
LT2908836T (lt)	2020-01-27	Farmacinė kompozicija, turinti kurkumino
PL2922571T3 (pl)	2018-03-30	Postać farmaceutyczna zawierająca metaloporfiryny zawierające karboran
BR112014021433A2 (pt)	2017-07-18	formulações farmacêuticas
BR302012003979S1 (pt)	2014-05-27	Configuração aplicada em fármaco
EP2851078A4 (en)	2015-10-21	PHARMACEUTICAL COMPOSITION
ECSP12011630A (es)	2012-02-29	Formulación farmacéutica
FR2986420B1 (fr)	2014-02-21	Pillulier
TH1401006714B (th)	2016-05-10	แคปซูล
UA25454S (uk)	2013-09-25	Флакон для лікарських засобів
UA25455S (uk)	2013-09-25	Флакон для лікарських засобів
UA24158S (uk)	2012-12-25	Флакон для лікарських засобів
UA24159S (uk)	2012-12-25	Флакон для лікарських засобів
UA24201S (uk)	2013-01-10	Флакон для лікарських засобів
UA25275S (uk)	2013-08-12	Флакон для лікарських засобів
CL2013001491S1 (es)	2014-06-06	Envase